Your browser doesn't support javascript.
loading
Can patients with asymptomatic SARS-CoV-2 infection safely undergo elective surgery?
Glasbey, James C; Dobbs, Thomas D; Abbott, Tom E F.
Afiliación
  • Glasbey JC; NIHR Global Health Research Unit on Global Surgery, Institute of Translational Medicine, Birmingham, UK.
  • Dobbs TD; Reconstructive Surgery and Regenerative Medicine Research Centre, Institute of Life Sciences, Swansea University Medical School, Swansea, UK; Welsh Centre for Burns and Plastic Surgery, Morriston Hospital, Swansea, UK.
  • Abbott TEF; Critical Care and Perioperative Medicine Research Group, William Harvey Research Institute, Queen Mary University of London, London, UK. Electronic address: t.abbott@qmul.ac.uk.
Br J Anaesth ; 128(6): 909-911, 2022 06.
Article en En | MEDLINE | ID: mdl-35369990
Current or recent infection with SARS-CoV-2 increases the risk of perioperative morbidity and mortality. Consensus guidelines recommend delaying elective major surgery after acute SARS-CoV-2 infection for 7 or 8 weeks. However, because of the growing backlog of untreated surgical disease and the potential risks of delaying surgery, surgical services may be under pressure to reduce this period. Here, we discuss the risks and benefits of delaying surgery for patients with current or recent SARS-CoV-2 infection in the context of the evolving COVID-19 pandemic, the limited evidence supporting delays to surgery, and the need for more research in this area.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Br J Anaesth Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Br J Anaesth Año: 2022 Tipo del documento: Article